[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368594-105":59,"doc-detail-368594-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epstein-barr-virus-antibody-and-cancer-risk-in-two-prospective-cohorts-in-southern-china","Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China","","Investigates the association between Epstein-Barr virus (EBV) VCA-IgA antibody levels and cancer risk using two large prospective cohorts from Southern China (73,939 adults). After around 8–10 years of follow-up, 964 and 1,026 incident cancer cases were identified in Zhongshan and Wuzhou cohorts. VCA-IgA seropositivity correlated with higher age-standardized total cancer incidence and increased risks for multiple cancers, including lung, liver, nasopharyngeal carcinoma, and lymphoma, showing a dose-response pattern and persistence up to ten years prior to diagnosis. The population-attributable risk for total cancer is estimated at 7.8%.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epstein-barr-virus-antibody-and-cancer-risk-in-two-prospective-cohorts-in-southern-china/368594/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epstein-barr-virus-antibody-and-cancer-risk-in-two-prospective-cohorts-in-southern-china/368594.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main research question about EBV in this study?","Question",{"text":112,"@type":113},"The study examined whether EBV VCA-IgA antibody levels are associated with the risk of developing cancer, including multiple specific cancer types, in Southern China cohorts.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many participants and follow-up duration were included?",{"text":117,"@type":113},"The analysis included 73,939 adults with a median follow-up approaching a decade, and cancer cases were identified over roughly 8–10 years.",{"name":119,"@type":110,"acceptedAnswer":120},"Which cancers showed increased risk with VCA-IgA seropositivity?",{"text":121,"@type":113},"Pooled analyses reported higher risks for total cancer and specific cancers, including lung cancer, liver cancer, nasopharyngeal carcinoma, and lymphoma, compared with seronegative individuals.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368594,1790197781,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article [https://doi.org/10.1038/s41467-025-60999-5](https://doi.org/10.1038/s41467-025-60999-5)  \nEpstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China  \nReceived: 2 August 2024  \n\n| Accepted: 6 June 2025 |\n| --- |\n| |\n| Check for updates |\n\nMing-Fang Ji 1,14, Yong-Qiao He 2,14 , Min-Zhong Tang3,4,14,  \nWen-Qiong Xue2,14, Xia Yu1,14, Hua Diao5, Da-Wei Yang5, Zhi-Ming Mai 6,7, Io Hong Cheong8, Zhi-Yang Zhao5, Biao-Hua Wu1, Fu-Gui Li1, Ji-Yun Zhan9, Chang-Ling Huang5, Hao-Lin Ma10, Jun Li3,4, Yan-Cheng Li3,4, Tong-Min Wang 2  \n,  \nYing Liao 2, Xue-Yin Chen2, Zhi-Heng Liang1, Shi-Feng Lian1, Yun Du11, Xue-Jun Liang9, Zisis Kozlakidis 12, Jun Ma2,13 & Wei-Hua Jia 2,5   \nEpstein-Barr virus (EBV) has been implicated in several human cancers, but its broader cancer risk remains unclear. We investigated the association between EBV VCA-IgA antibody levels and cancer risk in two large prospective cohorts from Southern China, comprising 73,939 adults. During around 8-10 years follow-up, 964 and 1026 incident cancer cases were identiﬁed in the Zhongshan and Wuzhou cohorts. VCA-IgA seropositivity was associated with higher age-standardized incidence rates for total cancer signiﬁcantly. In pooled analyses, VCA-IgA seropositive individuals had higher risks of total cancer (HR 4.88, 95% CI: 2.84-8.37), lung cancer (1.76, 1.23-2.54), liver cancer (1.70, 1.10- 2.63), nasopharyngeal carcinoma (26.05, 11.77-57.65), and lymphoma (3.20, 1.46-6.99) compared to seronegative individuals. The associations showed an increased dose-response pattern, and keep persistent even up to ten years prior to diagnosis. The population-attributable risk percentage for total cancer due to VCA-IgA seropositivity is estimated at 7.8%. These ﬁndings provide prospective evidence that EBV seropositivity is associated with increased risks of multiple cancers. This association results in a heightened attributed cancer burden in Southern China.  \nEpstein-Barr virus (EBV) is the most common and persistent human virus, affecting ~95% of the global population with asymptomatic lifelong infection1. While widespread in its host population, only a small proportion of EBV infections have been linked to human diseases, particularly those of lymphocytic and epithelial origin, with cancer being the most severe manifestation. Given its oncogenesis roles, EBV has been classiﬁed as a Group I carcinogen by the International Agency for Research on Cancer since 1997. Nevertheless, to date, only limited cancer types, such as certain histological subtypes of lymphomas, nasopharyngeal carcinoma (NPC), lymphoepithelioma-like carcinoma (LELC), and a minor proportion (~10%) of stomach cancer (although in controversial), have been directly linked to EBV infection2–4,  \naccounting for 239,700–357,900 new cases of cancer and 137,900–208,700 cancer deaths worldwide in 20205,6.  \nEBV primarily targets oropharyngeal epithelial cells and subsequently infects B cells, establishing a latent infection that allows the virus to evade the host’s immune response. Under certain conditions, EBV can undergo spontaneous reactivation, switching from latent to lytic phase, wherein the virus replicates, produces new viral particles, and induces speciﬁc antibodies targeting various EBV proteins7. The detection of antibodies against EBV proteins in the blood has been widely observed in several EBV-associated malignancies, including NPC. Among the over 80 gene products of EBV, the Viral Capsid Antigen (VCA) emerges as a key structure protein expressed in the late  \nA full list of afﬁliations appears at the end of the paper. e-mail: [heyq@sysucc.org.cn](heyq@sysucc.org.cn); [jiawh@sysucc.org.cn](jiawh@sysucc.org.cn)  \nphase of lytic replication, playing a vital role in viral assembly and transmission8. While VCA-IgA is not a deﬁnitive marker of lytic reactivation, its elevated levels are strongly associated with increased EBV activity and cancer risk9. Numerous prospective cohort studi","cbCaidqQcrcVbDM6","https://ap.wps.com/l/cbCaidqQcrcVbDM6","pdf",4170628,12,"English","# Background and rationale\n# Study design and cohorts\n# Results\n## Baseline cohort characteristics\n## Cancer incidence and risk associations\n## Dose-response and persistence\n# Conclusions and implications","[{\"question\":\"What was the main research question about EBV in this study?\",\"answer\":\"The study examined whether EBV VCA-IgA antibody levels are associated with the risk of developing cancer, including multiple specific cancer types, in Southern China cohorts.\"},{\"question\":\"How many participants and follow-up duration were included?\",\"answer\":\"The analysis included 73,939 adults with a median follow-up approaching a decade, and cancer cases were identified over roughly 8–10 years.\"},{\"question\":\"Which cancers showed increased risk with VCA-IgA seropositivity?\",\"answer\":\"Pooled analyses reported higher risks for total cancer and specific cancers, including lung cancer, liver cancer, nasopharyngeal carcinoma, and lymphoma, compared with seronegative individuals.\"}]","Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China | PDF",1790177649,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/892b30c814cc9d89f5ebd50718cae00a.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e525a32470c1ef0591caf9b763e4fe05.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5eb603e2b3ceac96e7c15d2bd6d838a8.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b5baf35d4ab2d505ff37ee8bcd4979a.webp",980,1301]